| Patents for C07D 295 - Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms (34,005) |
|---|
| 05/07/2013 | CA2509522C Ligands for metals and improved metal-catalyzed processes based thereon |
| 05/02/2013 | WO2013060860A1 N-acyl-n'-phenylpiperazine derivatives as srbp modulators for use in the treatment of diabetes and obesity |
| 05/02/2013 | US20130109698 Small Molecule Inhibitors of Functions of the HIV-1 Matrix Protein |
| 05/01/2013 | EP2586774A1 Method for preparation of ranolazine |
| 05/01/2013 | CN103080084A Process for the manufacture of TMHQ |
| 05/01/2013 | CN103073524A 4-[4-(substituted phenyl) piperazine piperazinyl-1]-butylcarbamic acid substituted aromatic ester derivative and preparation method thereof |
| 05/01/2013 | CN103073373A Alpha-hydroxymethyl-alpha-aryl-alpha-amino acid derivatives and preparation method thereof |
| 05/01/2013 | CN103071424A Medium-high temperature resistant viscoelasticity surfactant, clean fracturing fluid and preparation method |
| 05/01/2013 | CN102267959B Repaglinide crystal, preparation method thereof, and solid oral preparation containing same |
| 05/01/2013 | CN101863786B Water-soluble shikonin naphthazarin oxygen nucleus alkyl derivative and preparation and application methods thereof |
| 04/30/2013 | US8431699 Method for manufacture of 2-oxoimidazolidines |
| 04/30/2013 | US8431563 Compounds that interact with glucokinase regulatory protein for the treatment of diabetes |
| 04/25/2013 | WO2013022550A3 Small molecule inhibitors of ebola and lassa fever viruses |
| 04/25/2013 | US20130102609 Biaryl oxyacetic acid compounds |
| 04/25/2013 | US20130102555 Method of treating diabetes |
| 04/25/2013 | CA2852917A1 Amine cationic lipids and uses thereof |
| 04/24/2013 | EP2583958A1 Ligands for metals and improved metal-catalyzed processes based thereon |
| 04/24/2013 | EP2582669A1 Process for preparing a cyclic tertiary methylamine |
| 04/24/2013 | CN202893339U Tower type reaction device |
| 04/24/2013 | CN1802159B 2-phenoxy- and 2-phenylsulfomamide derivatives with CCR3 antagonistic activity for the treatment of asthma and other inflammatory or immunological disorders |
| 04/24/2013 | CN103059168A Benzophenone-type light initiator and preparation method thereof |
| 04/24/2013 | CN103058959A N-(2-(4-methylpiperazine-1-yl)-5-formylphenyl) amide compound and application thereof |
| 04/24/2013 | CN103058958A Synthetic method of roxatidine acetate hydrochloride |
| 04/24/2013 | CN103058957A NMDA receptor antagonists for neuroprotection |
| 04/24/2013 | CN103058805A Method for synthesizing amine and imine |
| 04/24/2013 | CN102212043B Preparation method of morpholine-based vegetable oil polyol |
| 04/24/2013 | CN102079729B Compounds with antiparasitic activity and medicaments containing them |
| 04/23/2013 | US8426587 Haloallylamine inhibitors of SSAO/VAP-1 and uses therefor |
| 04/23/2013 | US8426422 Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases |
| 04/23/2013 | US8426415 Human ADAM-10 inhibitors |
| 04/23/2013 | CA2569124C N-(2-benzyl)-2-phenylbutanamides as androgen receptor modulators |
| 04/23/2013 | CA2529257C Methods and compositions for treating amyloid-related diseases |
| 04/18/2013 | WO2013056229A1 The use of (2r, 6r)-hydroxynorketamine, (s)-dehydronorketamine and other stereoisomeric dehydro and hydroxylated metabolites of (r,s)- ketamine in the treatment of depression and neuropathic pain |
| 04/18/2013 | US20130096315 Certain chemical entities, compositions and methods |
| 04/18/2013 | US20130096138 Novel thiourea or urea derivative, preparation method thereof, and pharmaceutical composition for preventing or treating aids, containing same as active ingredient |
| 04/18/2013 | US20130096133 Procaspase-activating compounds and compositions |
| 04/18/2013 | CA2851619A1 The use of (2r, 6r)-hydroxynorketamine, (s)-dehydronorketamine and other stereoisomeric dehydro and hydroxylated metabolites of (r,s)- ketamine in the treatment of depression and neuropathic pain |
| 04/17/2013 | CN103044356A New method for synthesizing levocetirizine and key intermediate thereof |
| 04/17/2013 | CN103044355A Key intermediate for synthesizing levocetirizine and preparation method thereof |
| 04/17/2013 | CN103041606A Method for cleansing ionic liquid |
| 04/17/2013 | CN103040832A Application of substituted cyanobenzene in preparation of fungal infection resisting drugs |
| 04/17/2013 | CN102367241B Preparation method of ranolazine |
| 04/17/2013 | CN102142316B Ionic liquid, electrolyte salt for storage device, electrolytic solution for storage device, electric double layer capacitor, and secondary battery |
| 04/17/2013 | CN101898966B Piperazine ring-containing Artemisia rupestris L. keto ester derivative as well as preparation method thereof |
| 04/17/2013 | CN101466670B Inhibitors of histone deacetylase |
| 04/16/2013 | US8420640 Methods of treating amyloid disease using analogs of 1-(4-nitrophenyl) piperazine |
| 04/16/2013 | US8420632 Benzenesulfonamide compounds, method for synthesizing same, and use thereof in medicine as well as in cosmetics |
| 04/16/2013 | CA2527722C Biodegradable poly(beta-amino esters) and uses thereof |
| 04/11/2013 | WO2013006098A3 2,6-diisobornylphenol derivatives |
| 04/11/2013 | WO2012104788A3 Anti-angiogenic compounds, pharmaceutical compositions containing same, and use thereof |
| 04/11/2013 | US20130090475 Process for the Preparation of Ranolazine |
| 04/10/2013 | EP2575815A1 Glycine transporter-1 inhibitors, methods of making them, and uses thereof |
| 04/10/2013 | CN103030609A Method for preparing repaglinide |
| 04/10/2013 | CN102285962B Phenoxy alkyl piperazine compounds, preparation method thereof and medicinal use thereof |
| 04/10/2013 | CN102274736B Application of aluminum chloride in catalyzing amine and carbodiimide addition reaction |
| 04/10/2013 | CN101941953B Nitrogenous heterocyclic substituted hydrazide compounds as well as preparation methods and applications thereof |
| 04/10/2013 | CN101906084B Preparation method of piperazine and own derivatives |
| 04/09/2013 | CA2737565C N-phenyl-2-pyrimidine-amine derivatives |
| 04/09/2013 | CA2561555C Bicyclic aromatic sulfinyl derivatives |
| 04/09/2013 | CA2513915C New arylpiperazinyl compounds |
| 04/04/2013 | WO2013045487A1 Azo mediators |
| 04/04/2013 | CA2849044A1 Azo mediators |
| 04/03/2013 | CN103012319A Repaglinide intermediate synthesis process improvement |
| 04/03/2013 | CN103012318A Fluorobenzyl substituted piperazine compound and preparation and medical application thereof |
| 04/03/2013 | CN103012317A Alkyl phenyl derivative and application of alkyl phenyl derivative as photoinitiator |
| 04/03/2013 | CN103006659A Application of substituted piperazine compound in preparation of medicament for resisting fungal infection |
| 04/03/2013 | CN101979394B A method to inhibit ethylene responses in plants |
| 04/03/2013 | CN101921246B Monomer compound comprising several cationic groups and process for making the same |
| 04/03/2013 | CN101903096B Method for the production of an amine |
| 04/03/2013 | CN101489984B Aminoindan derivative or salt thereof |
| 04/02/2013 | CA2537292C 1- (2-amino-benzol) -piperazine derivatives as glycine uptake inhibitors for the treatment of psychoses |
| 03/28/2013 | WO2013042800A1 Chromene compound and curable composition |
| 03/28/2013 | US20130079514 "omega-aminoalkylamides of r-2-aryl-propionic acids as inhibitors of the chemotaxis of polymorphonucleate and mononucleate cells" |
| 03/28/2013 | CA2849282A1 Chromene compound and curable composition |
| 03/27/2013 | EP2573078A1 Acrylamide compounds and use thereof for inhibiting apoptosis |
| 03/27/2013 | CN103003253A Acid addition salts of the 2-[2-[[(4-methoxy-2,6-dimethylphenyl) sulfonyl]-(methyl)amino]ethoxy]-n-methyl-n-[3- (4-methylpiperazin-1-yl)cyclohexyl] acetamide and the use thereof as bradykinin b1 receptor antagonists |
| 03/27/2013 | CN103003234A N-hydroxyformamide derivative and pharmaceutical containing same |
| 03/27/2013 | CN102998915A Positive photoresist and stripping agent composition |
| 03/27/2013 | CN102993126A Cracking control device of acryloylmorpholine |
| 03/27/2013 | CN102993125A New kappa-opiate receptor stimulant having protection function on ischemia heart |
| 03/27/2013 | CN102993124A Substituted piperazidines compound as well as preparation method and pharmaceutical use thereof |
| 03/27/2013 | CN102993123A Macromolecule type poly-functional group alpha-amino alkyl acetophenone photoinitiator |
| 03/27/2013 | CN102993122A Novel synthesis path of trimetazidine hydrochloride |
| 03/27/2013 | CN102993121A Synthetic method for preparing roxatidine acetate hydrochloride with high purity |
| 03/27/2013 | CN102993120A Morpholine-containing ionic liquid and preparation method thereof as well as electrolyte and application thereof |
| 03/27/2013 | CN102993119A Imidazole-containing ionic liquid and preparation method thereof, and electrolyte and application thereof |
| 03/27/2013 | CN102993118A Piperidine-containing ionic liquid and preparation method thereof, and electrolyte and application thereof |
| 03/27/2013 | CN101903347B Piperidinyl and piperazinyl modulators of gamma-secretase |
| 03/27/2013 | CN101448785B Novel dipeptidyl peptidase iv inhibitors and processes for preparation and pharmaceutical compositions thereof containing the same |
| 03/27/2013 | CN101146786B Piperazinyl and piperidinyl ureas as modulators of fatty acid amide hydrolase |
| 03/27/2013 | CN101128427B Heterocyclic compounds as ccr2b antagonists |
| 03/21/2013 | WO2013039187A1 Guanidinobenzoic acid compound |
| 03/21/2013 | WO2013037907A1 Dye composition comprising a cationic para-aminophenol oxidation base |
| 03/21/2013 | US20130072677 Novel hydroxamic acid derivative |
| 03/21/2013 | US20130072491 Prophylactic or therapeutic agent for diabetes or obesity |
| 03/21/2013 | CA2848561A1 Guanidinobenzoic acid compound |
| 03/20/2013 | EP2570409A1 Aralkyl diamine derivatives and uses thereof as antidepressant |
| 03/20/2013 | EP2570408A1 Hexaketide compound and medicinal use thereof |
| 03/20/2013 | CN102985403A Novel arylamide derivatives having antiandrogenic properties |
| 03/20/2013 | CN102985399A Method for preparing chemical compounds of interest by nucleophilic aromatic substitution of aromatic carboxylic acid derivatives supporting at least one electro-attractive group |